12:00 AM
Jul 30, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BPM 31543: Phase I started

Berg Pharma began an open-label, U.S. Phase I trial to evaluate BPM 31543 applied to the scalp twice daily in about 18...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >